Namibian President Geingob to undergo treatment for cancerous cells

President Hage Geingob of Namibia is set to undergo treatment for "cancerous cells" following a routine medical check-up, as announced by the Namibian presidency on Friday.

WINDHOEK – President Hage Geingob of Namibia is set to undergo treatment for “cancerous cells” following a routine medical check-up, as announced by the Namibian presidency on Friday.

The health examination, which included a colonoscopy and a gastroscopy, revealed the presence of cancerous cells.

The president’s office issued a statement saying, “The president was due for a colonoscopy and a gastroscopy on 8 January 2024, which were followed up with a biopsy.”

The 82-year-old leader will now undergo appropriate treatment to address the detected cancerous cells.

Zimbabwe president Emmerson Mnangagwa and Namibian president Hage Geingob on the sidelines of the 78th United Nations General Assembly summit in New York.
FILE: Zimbabwe president Emmerson Mnangagwa and Namibian president Hage Geingob on the sidelines of the 78th United Nations General Assembly summit in New York.
Geingob health concerns

This is not the first time President Geingob has faced health challenges.

In 2013, a year before assuming his first term, he underwent brain surgery.

Last year, he underwent an aortic operation in South Africa.

The Namibian presidency assured the public that President Gein-gob will continue to fulfill his presidential duties alongside the Cabinet during the treatment period.

Namibia is gearing up for presidential and national assembly elections later in the year.

Geingob, who is currently serving his second term, was initially elected as president in 2014 after spending 12 years as the country’s longest-serving prime minister.

The president’s health condition adds a layer of uncertainty to the political landscape as the nation prepares for the upcoming elections.

RosGwen24 News
RosGwen24 News
Articles: 2803

Leave a Reply

Your email address will not be published. Required fields are marked *